Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant
Clinical trial NCT01174082 · TERMINATED
Trial details
- NCT number
- NCT01174082
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-20
- Primary completion
- 2017-02-23
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.